BUDESONIDE
Manner of administration:Rectal
Restriction
Indication: For prescribing by certain health practitioners
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 3 | DPMQ: $152.25 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Budenofalk | |||||
Manner of administration:Oral
Restriction
Indication: Eosinophilic oesophagitis
Treatment phase: Subsequent continuing treatment - Maintenance of remission
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $415.21 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Jorveza | |||||
Manner of administration:Oral
Restriction
Indication: Eosinophilic oesophagitis
Treatment phase: Subsequent continuing treatment - Maintenance of remission
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $415.21 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Jorveza | |||||
Manner of administration:Oral
Restriction
Indication: Eosinophilic oesophagitis
Treatment phase: Initial treatment - Induction of remission
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 90 | # of repeats: 1 | DPMQ: $618.43 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Jorveza | |||||
Manner of administration:Oral
Restriction
Indication: Eosinophilic oesophagitis
Treatment phase: First continuing treatment - until remission is confirmed
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 8 | DPMQ: $415.21 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Jorveza | |||||
Manner of administration:Oral
Restriction
Indication: Eosinophilic oesophagitis
Treatment phase: First continuing treatment - until remission is confirmed
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 8 | DPMQ: $415.21 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Jorveza | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 16695)
Indication: Mild to moderate Crohn disease
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 100 | # of repeats: 1 | DPMQ: $67.94 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Budenofalk | |||||